Chromadex Corp Stock
Price
Target price
€11.60
€11.60
-3.330%
-0.4
-3.330%
-
25.06.25 / Stuttgart Stock Exchange
WKN: A2AG5N / Symbol: CDXC / Name: ChromaDex / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Chromadex Corp Stock
Heavy losses for Chromadex Corp today as the stock fell by -€0.400 (-3.330%).
For the coming years our community has positive and negative things to say abot the Chromadex Corp stock. Criterium "EBIT Margin" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Chromadex Corp | -3.330% | 1.695% | 38.728% | 408.475% | 133.010% | 506.214% | 206.122% |
Intellia Therapeutics Inc | -0.240% | -1.985% | 1.612% | -63.394% | -27.884% | -83.812% | -57.212% |
Cardio3 Biosciences S.A. | 2.430% | -0.804% | -11.271% | 48.000% | -44.024% | -77.576% | -96.255% |
Polynovo Ltd | -3.150% | -3.788% | -9.286% | -53.986% | -47.521% | -21.118% | -58.766% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat